Form D · Other
EpiBone, Inc.
New York, NY · CIK 0001798436
Offering snapshot reported Oct 24, 2025 · SEC filing
- Reported sold
- $4.29M Offering amount: $4.3M
- Investors reported
- 131 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Sep 2, 2025 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Oct 24, 2025 | Initial | $4,287,429 | No comparison | 131 | SEC filing |
| Dec 27, 2022 | Initial | $18,453,016 | No comparison | 51 | SEC filing |
| Feb 12, 2021 | Initial | $750,000 | No comparison | 4 | SEC filing |
| Feb 6, 2020 | Initial | $24,328,308 | No comparison | 140 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-562009
Source: Form D, filed Oct 24, 2025. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Sarindr Bhumiratana | Director, Executive |
| Elma Hawkins | Director |
| Robert Langer | Director |
| Nina Tandon | Director, Executive |
| Gordana Vunjak Novakovic | Director |
| David Zhu | Director |
Issuer details
Industry: Other (See others in industry)
Address:
521 5 Th Ave, 17 Th Floor
New York, NY, 10175
New York, NY, 10175